Washington State University
Spokane, Washington, 99202, United States
NCT Number: NCT06626373
The objective of this human study is to determine if the metabolic benefits observed with other anthocyanin-rich berries extend to elderberries. To accomplish this, we performed a short-term controlled feeding study in overweight but healthy volunteers in a placebo-controlled crossover clinical trial. Major study endpoints included blood glucose and insulin response to a high-carbohydrate meal challenge, indirect calorimetry, and profiling of the fecal microbiome.
Looking for future studies?
Notify Me22 year–75 year
All sexes
Interventional
Not applicable
Spokane, Washington, 99202, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will consume elderberry juice 1-week.
Participants will consume placebo beverage twice/day for 1-week.
Time frame: 3.5 hours
Participants will be monitored by a metabolic cart at rest and while walking
Time frame: 3 hours
Blood will be collected following a meal tolerance test
Time frame: 5 minutes
Feces will be collected before and after the intervention
Washington State University
Other
Elderberry Consumption and Human Health: a Preliminary Investigation Into Effects on Indirect Calorimetry, Insulin Sensitivity, and Microbiome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04368858
Atherosclerosis of the Distal Arteries, Without Gangrene, Basal Ganglia Diseases
Clermont-Ferrand, France
View Trial DetailsNCT04375280
Atherosclerosis of the Distal Arteries, Without Gangrene, Basal Ganglia Diseases
Clermont-Ferrand, France
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial Details